Esperion Therapeutics
ESPR
#6026
Rank
S$1.24 B
Marketcap
S$5.27
Share price
6.53%
Change (1 day)
45.89%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -S$37.01 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are S$0.30 Billion. In 2024 the company made an earning of S$9.69 Million, an increase over its 2023 earnings that were of -S$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$37.01 Million-481.71%
2024 S$9.69 M-104.99%
2023 -S$0.2 Billion-15.03%
2022 -S$0.23 Billion-20.61%
2021 -S$0.29 Billion84.28%
2020 -S$0.16 Billion35.75%
2019 -S$0.12 Billion-55.71%
2018 -S$0.26 Billion19.57%
2017 -S$0.22 Billion125.39%
2016 -S$96.37 Million51.43%
2015 -S$63.64 Million36.45%
2014 -S$46.64 Million43.55%
2013 -S$32.49 Million145.26%
2012 -S$13.25 Million
2002 -S$37.77 Million-7.81%
2001 -S$40.97 Million15.03%
2000 -S$35.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-S$0.67 Billion 1,790.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.87 B-2,575.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.30 B-43,290.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$6.64 B-18,849.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$6.43 M-118.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-S$88.59 Million 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA